[go: up one dir, main page]

NO923331D0 - N-substituerte aminometandifosfonsyrer - Google Patents

N-substituerte aminometandifosfonsyrer

Info

Publication number
NO923331D0
NO923331D0 NO923331A NO923331A NO923331D0 NO 923331 D0 NO923331 D0 NO 923331D0 NO 923331 A NO923331 A NO 923331A NO 923331 A NO923331 A NO 923331A NO 923331 D0 NO923331 D0 NO 923331D0
Authority
NO
Norway
Prior art keywords
substituted
aminometandy
phosphonic acids
acids
alk1
Prior art date
Application number
NO923331A
Other languages
English (en)
Other versions
NO923331L (no
Inventor
Knut Alfred Jaeggi
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO923331D0 publication Critical patent/NO923331D0/no
Publication of NO923331L publication Critical patent/NO923331L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Dental Preparations (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
NO92923331A 1991-08-27 1992-08-26 N-substituerte aminometandifosfonsyrer NO923331L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91810682 1991-08-27

Publications (2)

Publication Number Publication Date
NO923331D0 true NO923331D0 (no) 1992-08-26
NO923331L NO923331L (no) 1993-03-01

Family

ID=8208873

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923331A NO923331L (no) 1991-08-27 1992-08-26 N-substituerte aminometandifosfonsyrer

Country Status (19)

Country Link
US (1) US5281748A (no)
EP (1) EP0531253B1 (no)
JP (1) JPH05222074A (no)
KR (1) KR930004317A (no)
AT (1) ATE147396T1 (no)
AU (1) AU657983B2 (no)
CA (1) CA2076801A1 (no)
DE (1) DE69216514T2 (no)
DK (1) DK0531253T3 (no)
ES (1) ES2096061T3 (no)
FI (1) FI923797A7 (no)
GR (1) GR3022243T3 (no)
HU (1) HUT62303A (no)
IL (1) IL102959A (no)
MX (1) MX9204905A (no)
NO (1) NO923331L (no)
NZ (1) NZ244078A (no)
TW (1) TW207543B (no)
ZA (1) ZA926434B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
TW258729B (no) * 1992-06-22 1995-10-01 Ciba Geigy
DE4223940A1 (de) * 1992-07-21 1994-01-27 Boehringer Mannheim Gmbh Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
GB9300641D0 (en) * 1993-01-14 1993-03-03 Zeneca Ltd Process
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
IT1303672B1 (it) 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2316396C3 (de) * 1973-04-02 1975-09-18 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen N(1,1-Di-phosphono-äthyl)acetamidin, seine Herste lung und Verwendung zur Steinverhütung
DE3208600A1 (de) * 1982-03-10 1983-09-22 Henkel KGaA, 4000 Düsseldorf Amidinodiphosphonsaeuren
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4963681A (en) * 1987-07-06 1990-10-16 Norwich Eaton Pharmaceuticals, Inc. Process for synthesis of aminomethylene phosphonoalkylphosphinates
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
US5043099A (en) * 1990-07-13 1991-08-27 Kreh Robert P Mono- and di-substituted (diphosphonoalkylamino methyl)-4-hydroxybenzenesulfonic acid
DE69116838T2 (de) * 1990-12-19 1996-06-13 Takeda Chemical Industries Ltd Bisphosphonsäurederivate, ihre Produktion und ihre Verwendung

Also Published As

Publication number Publication date
FI923797L (fi) 1993-02-28
ZA926434B (en) 1993-04-28
KR930004317A (ko) 1993-03-22
NZ244078A (en) 1994-12-22
TW207543B (no) 1993-06-11
DE69216514T2 (de) 1997-07-31
IL102959A0 (en) 1993-01-31
DK0531253T3 (da) 1997-01-27
EP0531253B1 (en) 1997-01-08
NO923331L (no) 1993-03-01
CA2076801A1 (en) 1993-02-28
GR3022243T3 (en) 1997-04-30
AU2128892A (en) 1993-03-04
US5281748A (en) 1994-01-25
MX9204905A (es) 1993-04-01
FI923797A0 (fi) 1992-08-24
HUT62303A (en) 1993-04-28
FI923797A7 (fi) 1993-02-28
IL102959A (en) 1998-01-04
HU9202754D0 (en) 1992-12-28
ES2096061T3 (es) 1997-03-01
EP0531253A1 (en) 1993-03-10
DE69216514D1 (de) 1997-02-20
ATE147396T1 (de) 1997-01-15
JPH05222074A (ja) 1993-08-31
AU657983B2 (en) 1995-03-30

Similar Documents

Publication Publication Date Title
FI940012A0 (fi) Aryylisulfonamidosubstituoidut hydroksaamihapot
MA22014A1 (fr) Derives d'acides amines .
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
DK1004578T3 (da) 5-oxo-pyrrolidin-2-carboxylsyrehydroxamidderivater
NO924915D0 (no) Sakkarinderivater med inhiberende virkning paa protolytiske enzymer
FI915920A0 (fi) Serotoninantagonister.
DE59203976D1 (de) Hydantoinderivate.
DE3851279D1 (de) Organische Salze von Physostigminderivaten.
DE69229442D1 (de) Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung
DE68923151D1 (de) Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen.
NZ212768A (en) 2-substituted-1,3-propylidene diphosphonate derivatives and pharmaceutical compositions
NO923331D0 (no) N-substituerte aminometandifosfonsyrer
DK0610078T3 (da) Cytotoksisk og antiviral forbindelse.
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
IL101560A0 (en) Condensed diazepinones,their preparation and pharmaceutical compositions containing them
EP0802179A4 (en) DERIVATE SUBSTITUTED AMIDINONAPHTHYLESTER
ATE81971T1 (de) Synergistische kombination von decarboxylasehemmern und l-dopa-pellets.
FI812773L (fi) Foerfarande foer framstaellning av n-/4-/(2,4-diamino-6-pteridinyl)-metyl/metylamino/benzoyl/glutaminsyra
RU97111543A (ru) Способ лечения неврологических нарушений, связанных с хронической формой врожденной вирусной инфекции